Nearly all patients with PV have a JAK2 (Janus kinase 2) mutation, of which 96% harbor the classic JAK2 V617F mutation in exon 14 and about 3% an exon 12 mutation (Table 1) [28,29,30,31,32,33]. The gene discussed is JAK2; the disease is acquired polycythemia vera.